Cellebrite concluded 2025 with a robust fourth quarter, marked by a 21% increase in total ARR to $480.8 million and an 18% rise in revenue to $128.8 million. The company achieved a net income of $21.3 million and an adjusted EBITDA of $38.3 million, reflecting strong operational performance and strategic progress, despite a challenging U.S. Federal spending environment.

Cellebrite delivered strong Q3 performance, driven by growth in subscription revenue and expansion in its U.S. federal business. Net income reached $20.2 million and revenue totaled $126 million, reflecting robust demand across key segments.

Cellebrite delivered an 18% increase in revenue and a 29% improvement in adjusted EBITDA in Q2 2025. The company posted $19.5 million in net income and free cash flow more than doubled year-over-year.

Cellebrite saw solid revenue growth driven by a 21% increase in subscription revenue, alongside improved profitability and strong ARR momentum.

Cellebrite delivered strong Q4 2024 results, with a 17% YoY revenue increase driven by a 21% rise in subscription revenue. The company maintained strong profitability with a 24.7% non-GAAP operating margin and achieved a net income turnaround from a loss in the previous year.